Menu
MapConnectionsTopicsBulgariaThe Night (K-TRIO)Marie Skłodowska-CurieFor studentsFor teachersMethodologySurprise me
H2020Staff exchange2016–2020

MAST4HEALTH · Mastiha treatment for healthy obese with NAFLD diagnosis (MAST4HEALTH).

Horizon 2020 — Marie Skłodowska-Curie Actions

Duration
2016-03-01 → 2020-02-29
EU contribution
€2,124,000
Participants
15
Scheme
MSCA-RISE

Lines connect the coordinator with its partners.

Results in brief

Mastiha treatment for healthy obese with NAFLD diagnosis (MAST4HEALTH).

Nonalcoholic fatty liver disease and steatohepatitis (NAFLD/NASH) is one of the most common liver disorders and a major public health problem in Europe and North America and one of the most common complications of obesity and diabetes mellitus in Western populations affecting approximately 50% of diabetics and 76% of obese patients. MAST4HEALTH consists a multidisciplinary approach to assess a non pharmacological intervention for managing NAFLD/NASH. Because of limitations in current NAFLD treatment therapies, many new efforts focus on exploring non-pharmacologic means for managing the disease and in particular through dietary substances or bioactive phytochemicals in fruits, vegetables, and plants or their products. MAST4HEALTH aimed at exploring the effect of Mastiha, a natural product of Greece which was recently shown to possess antioxidant/anti- inflammatory and lipid lowering properties. We completed a multicenter randomized double blind placebo controlled (parallel arm) clinical trial to test the effectiveness of Mastiha supplement as new non-pharmacologic strategy for NAFLD/NASH treatment. MAST4HEALTH explored gene-diet interactions, more specifically the potential personalized activity of the Mastiha, and correlated genetic and epigenetic markers with metabolomic and intestinal microbiota profiles pre- and post- intervention. The effectiveness of the proposed intervention was evaluated via clinical and laboratory markers of the disease. To this end, MAST4HEALTH trained a number of researchers and PhD students in multidisciplinary approaches of this survey. MAST4HEALTH built and enhanced cooperation among partners meanwhile strengthening the interaction between our academic and non-academic sectors

Data: CORDIS, © European Union

Project objective

MAST4HEALTH is set on the concept of a multidisciplinary approach to assess a non-pharmacological intervention for managing NAFLD/NASH, one of the most common complications of obesity and diabetes mellitus in Western populations affecting approximately 50% of diabetics and 76% of obese patients. Because of limitations in current NAFLD treatment therapies, many new efforts focus on exploring non-pharmacologic means for managing the disease and in particular through dietary substances or bioactive phytochemicals in fruits, vegetables, and plants or their products. MAST4HEALTH aims at exploring the effect of Mastiha, a natural product of Greece which was recently shown to possess antioxidant/anti-inflammatory and lipid lowering properties. We designed a multicenter randomized double blind placebo controlled (parallel arm) clinical trial to test the effectiveness of Mastiha supplement as new non-pharmacologic strategy for NAFLD/NASH treatment. MAST4HEALTH will explore gene-diet interactions, more specifically the potential personalized activity of the Mastiha, and correlate genetic and epigenetic markers with metabolomic and intestinal microbiota profiles pre- and post-intervention. The effectiveness of the proposed intervention will be evaluated via clinical and laboratory markers of the disease. To this end, MAST4HEALTH will train a number of researchers and PhD students in multidisciplinary approaches of this survey. MAST4HEALTH is expected to build and enhance cooperation among partners meanwhile strengthening the interaction between our academic and non-academic sectors

Original text from CORDIS.

Participants

  • CHAROKOPEIO PANEPISTIMIO · AthinaCoordinatorGreece
  • BIOTECH VANA SL · PATERNA (VALENCIA)Spain
  • CONSIGLIO NAZIONALE DELLE RICERCHE · RomaItaly
  • ENOSIS MASTICHOPARAGOGON CHIOU · ChiosGreece
  • FONDAZIONE IRCCS CA' GRANDA - OSPEDALE MAGGIORE POLICLINICO · MilanoItaly
  • FUNDACION PARA EL FOMENTO DE LA INVESTIGACION SANITARIA Y BIOMEDICA DE LA COMUNITAT VALENCIANA · ValenciaSpain
  • INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE · ParisFrance
  • MARASCIO FERNANDOItaly
  • PERSPECTUM LTD · OXFORDUnited Kingdom
  • QUEEN MARY UNIVERSITY OF LONDON · LONDONUnited Kingdom
  • Randox Laboratories Ltd · CrumlinUnited Kingdom
  • SANOFI-AVENTIS DEUTSCHLAND GMBH · Frankfurt Am MainGermany
  • UNIVERSITA DEGLI STUDI DI MILANO · MilanoItaly
  • UNIVERSITY OF NOVI SAD, FACULTY OF MEDICINE NOVI SAD · NOVI SADSerbia
  • UNIVERZITET U ISTOCNOM SARAJEVU · ISTOCNO NOVO SARAJEVOBosnia & Herzegovina

Links

Data: CORDIS, © European Union